IL-23 Blockade for Crohn s disease: next generation of anti-cytokine therapy.
about
Predicting corticosteroid-free endoscopic remission with vedolizumab in ulcerative colitis.Dust mite induces multiple polar T cell axes in human skin.A systems pharmacology model for inflammatory bowel disease.Advances in Biomarker-Guided Therapy for Pediatric- and Adult-Onset Neuroinflammatory Disorders: Targeting Chemokines/Cytokines.
P2860
IL-23 Blockade for Crohn s disease: next generation of anti-cytokine therapy.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
IL-23 Blockade for Crohn s disease: next generation of anti-cytokine therapy.
@en
IL-23 Blockade for Crohn s disease: next generation of anti-cytokine therapy.
@nl
type
label
IL-23 Blockade for Crohn s disease: next generation of anti-cytokine therapy.
@en
IL-23 Blockade for Crohn s disease: next generation of anti-cytokine therapy.
@nl
prefLabel
IL-23 Blockade for Crohn s disease: next generation of anti-cytokine therapy.
@en
IL-23 Blockade for Crohn s disease: next generation of anti-cytokine therapy.
@nl
P2093
P2860
P1476
IL-23 Blockade for Crohn s disease: next generation of anti-cytokine therapy.
@en
P2093
Carmen Correale
Clelia Cicerone
Federica Furfaro
Mariangela Allocca
Silvio Danese
P2860
P304
P356
10.1080/1744666X.2017.1279055
P577
2017-01-09T00:00:00Z